Acquiring Company
Anthropic
Acquired Company
Mithril Medicine
San FranciscoSan FranciscoArtificial IntelligenceCyber SecurityMachine LearningNatural Language ProcessingBiotechnologyArtificial IntelligenceMachine LearningDescription
Anthropic has acquired Mithril Medicine, a drug discovery startup, as part of its push into the life sciences. The target is described as a one-man stealth startup run by a pseudonymous Twitter poster. The text does not provide a deal date.
Who to call at Anthropic, and when
When Anthropic changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Anthropic raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Anthropic, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Anthropic. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Anthropic makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Mithril Medicine?
Mithril Medicine was acquired by Anthropic, based in San Francisco. The deal was reported on October 28, 2026. Learn the critical role of AI & ML in cybersecurity and industry specific case studies. Watch on-demand sessions today. Anthropic is privately held and operates in Artificial Intelligence.
When did Anthropic acquire Mithril Medicine?
Anthropic's acquisition of Mithril Medicine was reported on October 28, 2026. Anthropic has acquired Mithril Medicine, a drug discovery startup, as part of its push into the life sciences. The target is described as a one-man stealth startup run by a pseudonymous Twitter poster. The text does not provide a deal date. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Mithril Medicine do?
Mithril Medicine is a one-man stealth drug discovery startup run by a pseudonymous Twitter poster. It is privately held, operating in Biotechnology, and is based in San Francisco.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.